NewcelX Ltd., 2026-05-13
An SEC Form D private-offering notice from Kloten, a $3,428,989 filer-stated offering target in Biotech. Filed 2026-05-13. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotechnology company developing cell-based and small-molecule therapies for neurodegenerative and metabolic diseases, including Type 1 diabetes and ALS.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Pillar Therapeutics, Inc., 2026-05-13, $25M, Boston, MA
- Federated Biologics Inc., 2026-05-13, $4.4M, Alexandria
- Sentrimed, Inc., 2026-05-13, $1M, Mullica Hill, NJ
- California Compounding Company, Inc., 2026-05-12, $14.5M, Los Angeles, CA
- Pagari Life Science Corp., 2026-05-12, $300K, Bethalta, IL
- Axenic Health Solutions, Inc., 2026-05-12, $1M, Libertyville, IL
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.